Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
The Delta Variant Has Made Quest Diagnostics Indispensable
06:40am, Wednesday, 29'th Sep 2021
On the back of steady demand for COVID-19 testing, Quest Diagnostics bumped up its guidance for this year.
3 Top Stocks From the Buoyant Outpatient Home Health Industry
12:23pm, Tuesday, 28'th Sep 2021
Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. EHC, RDNT and
SECAUCUS, N.J., Sept. 28, 2021 /PRNewswire/ -- One in two (50.5%) American children under six years of age tested have detectable levels of lead, a toxic metal, in their blood, according to a new Hea
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
12:16pm, Wednesday, 22'nd Sep 2021
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics' (DGX) COVID-19 Test Demand Up in Q3 Months
09:57am, Monday, 20'th Sep 2021
The "Path Out of the Pandemic" plan of the U.S. Government, while emphasizing more on a magnified access for testing, comes as a major breakthrough for Quest Diagnostics (DGX).
3 Diagnostics Stocks in Focus on Biden's Delta Variant Mandate
11:27am, Tuesday, 14'th Sep 2021
Stocks like Quest Diagnostics (DGX), Quidel Corporation (QDEL) and LabCorp (LH) are the right picks now, thanks to rising COVID-19 testing demand.
Quest Diagnostic (DGX) Raises View on COVID-19 Testing Surge
10:51am, Friday, 10'th Sep 2021
Going by the current situation of daily increase in the coronavirus case count, Quest Diagnostics (DGX) expects COVID-19 molecular testing volumes to remain stronger through the rest of the year.
Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests
09:55am, Thursday, 09'th Sep 2021
Since Quest Diagnostics Incorporated (NYSE: DGX) reported its Q2 FY21 financial results, COVID-19 molecular testing volumes were stronger than anticipated through the end of August. Related Content:
Quest Diagnostics hikes financial estimates on Delta variant testing boost
07:17am, Thursday, 09'th Sep 2021
Quest Diagnostics Inc. DGX, +1.58% on Thursday raised its 2021 financial outlook on the heels of increased testing activity for Covid-19. Since the company issued its last projections on July 22, it's
Quest Diagnostics Updates Outlook For Full Year 2021
06:45am, Thursday, 09'th Sep 2021
SECAUCUS, N.J., Sept. 9, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its financial outlook for ful
Quest Diagnostics to Speak at the Morgan Stanley 19th Annual Global Healthcare Conference
11:18am, Monday, 30'th Aug 2021
SECAUCUS, N.J., Aug. 30, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at th
Quest Diagnostics: A Leader In Its Industry, With COVID Tailwinds Driving Revenue
10:18am, Friday, 27'th Aug 2021
Quest is a member of a duopoly. As such, it has a strong pricing advantage related to scale.
Quest Diagnostics Elects Tracey C. Doi to Board of Directors
06:45am, Tuesday, 17'th Aug 2021
SECAUCUS, N.J., Aug. 17, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected
Quest Diagnostics Declares Quarterly Cash Dividend
06:30pm, Monday, 16'th Aug 2021
SECAUCUS, N.J., Aug. 16, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a q
Quest Diagnostics (DGX), eMed Deal to Boost BinaxNOW Sales
01:59pm, Thursday, 12'th Aug 2021
Under the collaboration, eMed's Certified Guide will supervise Quest Diagnostics' (DGX) BinaxNOW home testing process virtually.
